Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination

Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination

US Patent 10016421 · Granted Jul 10, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HDAC6-activated macrophages, compositions, and uses thereof2025
Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors2024
Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors2022
Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor2021
Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor2021
Bromodomain inhibitor as adjuvant in cancer immunotherapy2020
Histone deacetylase as a modulator of PDLI expression and activity2020
Histone deacetylase as a modulator of PDLI expression and activity2020
Selective histone deactylase 6 inhibitors2019
Selective histone deactylase 6 inhibitors2019
Histone deacetylase as a modulator of PDL1 expression and activity2018
Histone deacetylase as a modulator of PDL1 expression and activity2018